About Azacytin 100mg Injection
Azacytin 100mg Injection
Product Name: Azacytin 100mg Injection
Composition: Azacitidine 100mg
Dosage Form: Injection
Packaging Type: Vial
Manufacturer: Dr. Reddys Laboratories
Product Description:
Azacytin 100mg Injection contains Azacitidine, an anticancer medicine used in the treatment of certain blood disorders and cancers including Myelodysplastic Syndromes (MDS) and related hematological conditions. It works by interfering with abnormal cell growth and supports normal blood cell development under specialist medical supervision.
This prescription-based oncology injection is administered only by qualified healthcare professionals. Treatment schedule and dosage are determined according to the patients medical condition and treatment protocol.
Features:
Contains Azacitidine 100mg
Oncology specialty product
Quality-assured packaging
Intended for hospital and clinical use
Specialized Anticancer TherapyAzacytin 100mg Injection is an important therapeutic option for adults diagnosed with myelodysplastic syndromes. As a hypomethylating agent, this medicine works by modulating abnormal cell growth, helping to manage hematologic disorders when prescribed by a specialist. Given its application in complex cancers, appropriate handling and administration are critical for optimal benefit.
Proper Administration and UseThis medication is available exclusively by prescription and should only be administered by healthcare professionals via subcutaneous or intravenous injection. The dosing and frequency depend on individual patient needs and should be followed as per the oncologist's recommendations. Patients should not self-administer the injection.
Storage and Handling GuidelinesAzacytin 100mg Injection must be stored below 25C as per label guidelines and used within 24 hours of preparation. Healthcare providers, retailers, and wholesalers must ensure proper cold chain management to maintain drug efficacy and safety during transportation and storage.
FAQ's of Azacytin 100mg Injection:
Q: How should Azacytin 100mg Injection be administered?
A: Azacytin 100mg Injection must be administered by a healthcare professional via subcutaneous or intravenous injection, following the exact dosage and schedule recommended by the treating physician.
Q: What medical conditions is Azacytin 100mg Injection indicated for?
A: This injection is primarily indicated for the treatment of myelodysplastic syndromes, including refractory anemia and chronic myelomonocytic leukemia, as determined by your doctor.
Q: When should Azacytin 100mg Injection be used during cancer therapy?
A: Azacytin is typically introduced after diagnosis of myelodysplastic syndromes, based on your doctor's judgment and treatment plan. Timing and duration of therapy are tailored for each patient.
Q: Where should I store Azacytin 100mg Injection before and after reconstitution?
A: Before use, store the vial below 25C according to the instructions on the label. Once prepared (reconstituted), the injection should be used within 24 hours to ensure effectiveness.
Q: What is the process for preparing and administering Azacytin 100mg Injection?
A: A trained healthcare provider will reconstitute the powder in the glass vial and then administer the injection either subcutaneously or intravenously. Patients should never attempt to prepare or inject the medication themselves.
Q: What are the benefits of using Azacytin 100mg Injection?
A: Azacytin can help control abnormal blood cell production in myelodysplastic syndromes, potentially improving blood counts and quality of life when used as part of a prescribed treatment plan.
Q: Is a prescription required to obtain Azacytin 100mg Injection?
A: Yes, Azacytin 100mg Injection is a prescription medication and should only be dispensed upon authorization from a qualified healthcare provider.